Nancy Dreyer

Nancy Dreyer is a pioneer in real-world evidence methodology who has developed frameworks for generating regulatory-grade evidence from observational oncology data. Her work at IQVIA has established standards for RWE study design that meet FDA and EMA requirements for supplemental approvals. She has authored influential guidance on best practices for oncology real-world data collection and analysis.